Serum prolidase activity and oxidative status in patients with stage I endometrial cancer

International Journal of Gynecological Cancer

Volumn 19, Issue 7, 2009, Pages 1244-1247

  Arioz, Dagistan Tolga ^a   Camuzcuoglu, Hakan ^b   Toy, Harun ^b   Kurt, Sefa ^c   Celik, Hakim ^b   Aksoy, Nurten ^b  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

^c Aegean Maternity and Women's Health Hospital   (Turkey)

Author keywords

Endometrial cancer; Local invasion; Oxidative stress; Prolidase activity

Indexed keywords

PROLINE DIPEPTIDASE; THIOL DERIVATIVE; ANTIOXIDANT; DIPEPTIDASE; FREE RADICAL; OXIDIZING AGENT; TUMOR MARKER;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; OXIDATION; PRIORITY JOURNAL; BLOOD; CANCER INVASION; CANCER STAGING; CASE CONTROL STUDY; ENDOMETRIUM TUMOR; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY;

ADULT; ANTIOXIDANTS; CARCINOMA, ENDOMETRIOID; CASE-CONTROL STUDIES; DIPEPTIDASES; ENDOMETRIAL NEOPLASMS; FEMALE; FREE RADICALS; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OXIDANTS; OXIDATIVE STRESS; SULFHYDRYL COMPOUNDS; TUMOR MARKERS, BIOLOGICAL;

EID: 73449125189     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181af711e     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
2. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med. 1996;74:297-312.
3. Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44-84.
4. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis. 2000;21: 361-370.
5. Ricard-Blum S, Ruggiero F. The collagen superfamily: from the extracellular matrix to the cell membrane. Pathol Biol. 2005;53: 430-442.
6. Surazynski A, Donald SP, Cooper SK, et al. Extracellular matrix and HIF-1 signaling: the role of prolidase. Int J Cancer. 2008;122: 1435-1440.
7. Cechowska-Pasko M, Palka J, Wojtukiewicz MZ. Enhanced prolidase activity and decreased collagen content in breast cancer tissue. Int J Exp Pathol. 2006;87:289-296.
8. Myara I, Charpentier C, Lemonnier A. Prolidase and prolidase deficiency. Life Sci. 1984;34:1985-1998.
9. Liu G, Nakayama K, Awata S, et al. Prolidase isoenzymes in the rat: their organ distribution, developmental change and specific inhibitors. Pediatr Res. 2007;62:54-59.
10. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37:112-119.
11. Hu ML, Louie S, Cross CE, et al. Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med. 1993;121:257-262.
12. Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria. Clin Chim Acta. 1982;125:193-205.
13. Duffy MJ. Proteases as prognostic markers in cancer. Clin Cancer Res. 1996;2:613-618.
14. Palka JA, Phang JM. Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem. 1997;67:166-175.
15. Myara I, Myara A, Mangeot M, et al. Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin Chem. 1984;30:211-215.
16. Altindag O, Erel O, Aksoy N, et al. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int. 2007;27:339-344.
17. Karna E, Surazynski A, Palka J. Collagen metabolism disturbances are accompanied by an increase in prolidase activity in lung carcinoma planoepitheliale. Int J Exp Pathol. 2000;81:341-347.
18. Guszczyn T, Sobolewski K. Deregulation of collagen metabolism in human stomach cancer. Pathobiology. 2004;71:308-313.
19. Palka J, Surazynski A, Karna E, et al. Prolidase activity disregulation in chronic pancreatitis and pancreatic cancer. Hepatogastroenterology. 2002;49:1699-1703.
20. Palka JA, Phang JM. Prolidase in human breast cancer MCF-7 cells. Cancer Lett. 1998;127:63-70.
21. Kaynar H, Meral M, Turhan H, et al. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and nonYsmall cell lung cancer. Cancer Lett. 2005;227:133-139.
22. Gonenc A, Ozkan Y, Torun M, et al. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther. 2001; 26:141-144.
23. Manoharan S, Kolanjiappan K, Kayalvizhi M. Enhanced lipid peroxidation and impaired enzymic antioxidant activities in the erythrocytes of patients with cervical carcinoma. Cell Mol Biol Lett. 2004;9:699-707.
24. Pejić S, Kasapović J, Todorović A, et al. Lipid peroxidation and antioxidant status in blood of patients with uterine myoma, endometrial polypus, hyperplastic and malignant endometrium. Biol Res. 2006; 39:619-629.
25. Camuzcuoglu H, Arioz DT, Toy H, et al. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer. Gynecol Oncol. 2009;112:481-485.